Clicky

W World Corp.(WWHC)

Description: W World Corp., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders. The company focuses on the disorders of the brain-gut axis, pain/inflammation, and autoimmune, as well as gout disorders. Its lead compounds under clinically development include Levotofisopam, a non-sedating agent for the treatment of Gout; and Dextofisopam, a non-serotonergic agent, which has completed Phase IIa and Phase IIb clinical trials for the treatment of irritable bowel syndrome. The company was founded in 1990 and is headquartered in North Las Vegas, Nevada.


Keywords: Medicine Biopharmaceutical Clinical Medicine Inflammation Disorders Autoimmunity Abdominal Pain Toner Irritable Bowel Syndrome Gout Axis Pain/Inflammation Treatment Of Irritable Bowel Syndrome

Home Page: www.pharmoscorp.com

3609 Hammerkop Drive
North Las Vegas, NV 89084
United States
Phone: 415 841 3570


Officers

Name Title
Mr. Eric W. Fangmann Acting Pres & Acting CFO

Exchange: PINK

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 15.9453
Price-to-Sales TTM: 0
IPO Date:
Fiscal Year End: December
Full Time Employees: 2
Back to stocks